Chances are the SP will improve during the last few weeks before the EMA opinion is handed down, which would be a good opportunity to make a placement without causing excessive dilution. Don't forget there is an appeal provision if a negative decision is returned - this would take about a month, so all would not be lost.
Whichever way it goes we'll need to raise funds to cover FDA trials in the US.
Capital Raise in Jan before the decision?, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
